May 20th, 2019
•Patient-derived xenograft (PDX) models more robustly recapitulate melanoma molecular and biological features and are more predictive of therapy response compared to traditional plastic tissue culture-based assays. Here we describe our standard operating protocol for the establishment of new PDX models and the characterization/experimentation of existing PDX models.
Related Videos
Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies Video (Video) | JoVE
Labeling of Breast Cancer Patient-derived Xenografts with Traceable Reporters for Tumor Growth and Metastasis Studies Video (Video) | JoVE
Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma Video (Video) | JoVE
Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma Video (Video) | JoVE
A 3D Organotypic Melanoma Spheroid Skin Model Video (Video) | JoVE
Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis Video (Video) | JoVE
Patient-derived Heterogeneous Xenograft Model of Pancreatic Cancer Using Zebrafish Larvae as Hosts for Comparative Drug Assessment Video (Video) | JoVE
Establishment of Gastric Cancer Patient-derived Xenograft Models and Primary Cell Lines Video (Video) | JoVE
Generation of a Liver Orthotopic Human Uveal Melanoma Xenograft Platform in Immunodeficient Mice Video (Video) | JoVE
The Establishment and Utilization of Patient Derived Xenograft Models of Central Nervous System Metastasis Video (Video) | JoVE
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved